Literature DB >> 8589224

Designed extension of studies based on conditional power.

M A Proschan1, S A Hunsberger.   

Abstract

We propose a flexible method of extending a study based on conditional power. The possibility for extension when the p value at the planned end is small but not statistically significant is built in to the design of the study. The significance of the treatment difference at the planned end is used to determine the number of additional observations needed and the critical value necessary for use after accruing those additional observations. It may therefore be thought of as a two-stage procedure. Even though the observed treatment difference at stage 1 is used to make decisions, the Type I error rate is protected.

Mesh:

Substances:

Year:  1995        PMID: 8589224

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  49 in total

Review 1.  Adaptive trial designs.

Authors:  Tze Leung Lai; Philip William Lavori; Mei-Chiung Shih
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-08-11       Impact factor: 13.820

Review 2.  Successful aging: Advancing the science of physical independence in older adults.

Authors:  Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor
Journal:  Ageing Res Rev       Date:  2015-10-14       Impact factor: 10.895

3.  The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  BMJ       Date:  2020-06-17

4.  Flexible design for following up positive findings.

Authors:  Kai Yu; Nilanjan Chatterjee; William Wheeler; Qizhai Li; Sophia Wang; Nathaniel Rothman; Sholom Wacholder
Journal:  Am J Hum Genet       Date:  2007-08-03       Impact factor: 11.025

5.  A Bayesian adaptive design for two-stage clinical trials with survival data.

Authors:  Uttam Bandyopadhyay; Atanu Biswas; Rahul Bhattacharya
Journal:  Lifetime Data Anal       Date:  2009-11-04       Impact factor: 1.588

6.  Longitudinal clinical trials with adaptive choice of follow-up time.

Authors:  Neal Jeffries; Nancy L Geller
Journal:  Biometrics       Date:  2015-03-27       Impact factor: 2.571

7.  Adaptive clinical trial designs in oncology.

Authors:  Yong Zang; J Jack Lee
Journal:  Chin Clin Oncol       Date:  2014-12

8.  Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment.

Authors:  M Rosenblum; M J Van der Laan
Journal:  Biometrika       Date:  2011-12       Impact factor: 2.445

9.  A model-based conditional power assessment for decision making in randomized controlled trial studies.

Authors:  Baiming Zou; Jianwen Cai; Gary G Koch; Haibo Zhou; Fei Zou
Journal:  Stat Med       Date:  2017-09-04       Impact factor: 2.373

Review 10.  A comparison of phase II study strategies.

Authors:  Sally Hunsberger; Yingdong Zhao; Richard Simon
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.